Home › Forums › Embryology (includes PGT & IVM) › Join us for the upcoming ASPIRE Webinar session on Embryology! › Reply To: Join us for the upcoming ASPIRE Webinar session on Embryology!
For the upcoming webinar, I will be speaking on the topic titled “KPIs in the ART Labs: Select Meaningful Indicators and Set Actionable Targets”
Here is an abstract of my presentation:
The World Health Organisation has estimated one in five couples to be affected by sub-fertility, worldwide. As the ART industry grows on an exponential scale, maintaining an efficient quality management system (QMS) in the ART lab is more vital than ever to provide safe and effective treatment. A good QMS constitutes of two main components; quality control and quality assurance. These include appropriate indicators to evaluate all aspects of the clinic; Reference indicators (RI), performance indicators (PI), and key performance indicators (KPI). KPIs are a set of quantifiable measurements used to review the overall performance of the clinic. The Vienna Consensus, published in 2017, established a series of minimum performance (competence) levels and aspirational (benchmark) values, to monitor both laboratory and clinical aspects of ART. KPIs must be established for each step of the ART cycle; fertilization rate, cleavage rate, implantation rate, fetal heart rate etc. Moreover, it was recommended that attainable benchmarks must be set according to the specifics of the laboratory; infrastructure, organisation etc. Given the distinct and complex nature of ART, there is an unavoidable struggle of constant troubleshooting to ensure KPIs match up to the set targets and prevent adverse events. Nonetheless, this is critical to ensure high quality care for the welfare of both the patients and the offspring.
I look forward to have an engaging session with you during the live webinar session on 31 Oct 2020, 5pm (GMT+8). Do feel free to also share any thoughts, questions, interesting information in this discussion thread as well.
Looking forward to hearing from everyone.